Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines V Fustaino, D Presutti, T Colombo, B Cardinali, G Papoff, R Brandi, ... Oncotarget 8 (61), 103340, 2017 | 57 | 2017 |
CASP4 gene silencing in epithelial cancer cells leads to impairment of cell migration, cell-matrix adhesion and tissue invasion G Papoff, D Presutti, C Lalli, G Bolasco, S Santini, C Manelfi, V Fustaino, ... Scientific reports 8 (1), 17705, 2018 | 36 | 2018 |
MET gene amplification and MET receptor activation are not sufficient to predict efficacy of combined MET and EGFR inhibitors in EGFR TKI-resistant NSCLC cells D Presutti, S Santini, B Cardinali, G Papoff, C Lalli, S Samperna, ... PLoS One 10 (11), e0143333, 2015 | 31 | 2015 |
Drug effects on metabolic profiles of Schistosoma mansoni adult male parasites detected by 1H-NMR spectroscopy A Guidi, G Petrella, V Fustaino, F Saccoccia, S Lentini, R Gimmelli, ... PLoS Neglected Tropical Diseases 14 (10), e0008767, 2020 | 10 | 2020 |
Gene expression profiling of hypoxic response in different models of senescent endothelial cells MP Mongiardi, M Merolle, V Fustaino, A Levi, ML Falchetti Aging Clinical and Experimental Research 33, 1993-2001, 2021 | 8 | 2021 |
Clustering and classification techniques for gene expression profile pattern analysis E Weitschek, G Fiscon, V Fustaino, G Felici, P Bertolazzi Pattern Recognition in Computational Molecular Biology: Techniques and …, 2015 | 6 | 2015 |
Modulation of cAMP/cGMP signaling as prevention of congenital heart defects in Pde2A deficient embryos: a matter of oxidative stress S Cardarelli, M Biglietto, T Orsini, V Fustaino, L Monaco, ... Cell Death & Disease 15 (2), 169, 2024 | 4 | 2024 |
Co-Expression Network Analysis Unveiled lncRNA-mRNA Links Correlated to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance and/or Intermediate Epithelial-to … V Fustaino, G Papoff, F Ruberti, G Ruberti International Journal of Molecular Sciences 25 (7), 3863, 2024 | 1 | 2024 |
The activity of a PI3K δ-sparing inhibitor, MEN1611, in non-small cell lung cancer cells with constitutive activation of the PI3K/AKT/mTOR pathway G Papoff, D Presutti, V Fustaino, A Parente, C Calandriello, S Alemà, ... Frontiers in Oncology 13, 1283951, 2023 | 1 | 2023 |
Mitochondrial Genome Profile in Demyelinating Diseases V Durastanti, A Monaco, B Caronti, A Cortese, V Fustaino, E Wang, ... JOURNAL OF NEUROLOGY & NEUROPHYSIOLOGY 5, 2013 | 1 | 2013 |
Inhibition of cAMP signaling prevents congenital heart defects counteracting oxidative stress in Pde2A deficient embryos S Cardarelli, M Biglietto, T Orsini, V Fustaino, L Monaco, ... bioRxiv, 2023.05. 29.542779, 2023 | | 2023 |
Comparative metabolic profiling by 1H-NMR spectroscopy analysis reveals the adaptation of S. mansoni from its host to in vitro culture conditions: a pilot study with ex vivo … V Fustaino, R Gimmelli, A Guidi, S Lentini, F Saccoccia, G Petrella, ... Parasitology Research 121 (4), 1191-1198, 2022 | | 2022 |
Characterization of an EMT intermediate phenotype associated to resistance to EGFR inhibitors in non small cell lung cancer cell lines V Fustaino, D Presutti, T Colombo, B Cardinali, G Papoff, R Brandi, ... 12th SIBBM Seminar Frontiers in Molecular Biology, From Single Cell Analysis …, 2016 | | 2016 |
Analysis of microarray and RNA-sequencing gene expression profiles through clustering and classification techniques E Weitschek, G Fiscon, V Fustaino, G Felici, P Bertolazzi | | 2014 |
INTEGRATED ANALYSIS OF DNA COPY NUMBER AND GENE EXPRESSION DATA IN LUNG CANCER MODELS OF RESISTANCE TO TARGETED THERAPY V Fustaino, D Presutti, B Cardinali, T Colombo, G Papoff, S Santini, C Lalli, ... BITS annual meeting 2014, 169-170, 2014 | | 2014 |